Matl I, Jirka J, Kocandrle V, Petrásek R
Program výzkumu transplantací orgánů, Institutu klinické a experimentální medicíny, Praha.
Cas Lek Cesk. 1990 May 4;129(18):550-3.
Two groups of patient after a first renal transplantation from a dead donor were treated by a double combination of cyclosporin A and prednisone (group A) and triple combination cyclosporin A and azathioprin and prednisone (group B). The groups were similar as regards effectiveness of treatment (evaluated with regard to the survival of recipients and grafts and the number of rejection episodes); they did not differ as to the losses of grafts for other than immunity reasons, which predominated in both groups over losses caused by rejection. Discontinuation of prednisone after four months in group A was complicated by rejection in 54%. Discontinuation of cyclosporin A after one year's treatment and a change to azothioprin and prednisone treatment was in both groups complicated by rejection in cca one fifth of the patients.
两组接受来自死亡供体首次肾移植的患者,分别接受环孢素A与泼尼松的双重联合治疗(A组)以及环孢素A、硫唑嘌呤与泼尼松的三重联合治疗(B组)。两组在治疗效果方面相似(根据受者和移植物的存活情况以及排斥反应发作次数进行评估);在因非免疫原因导致的移植物丢失方面没有差异,在两组中,非免疫原因导致的移植物丢失都比排斥反应导致的丢失更为常见。A组在四个月后停用泼尼松,54%的患者出现排斥反应并发症。两组在接受一年治疗后停用环孢素A并改为硫唑嘌呤与泼尼松治疗时,约五分之一的患者出现排斥反应并发症。